CAR-T therapies are lifesaving but resource-intensive, often requiring long inpatient stays. Sarah Cannon Cancer Institute of HCA Healthcare faced rising demand for these therapies and recognized the need for a more scalable, patient-friendly model.
By implementing a high-touch care-at-home model and developing new care pathways, Sarah Cannon successfully transitioned over 75% of CAR-T treatments to the outpatient setting, improving both efficiency and patient experience.
In this case study, you’ll discover:
-
How leveraging technology enabled early detection of life-threatening complications like CRS and ICANS
-
The impact on patients and caregivers, with continuous monitoring reducing stress and supporting at-home recovery
-
Measurable outcomes: 1,200+ hospital bed days saved, shortened inpatient stays (median 4 days vs. 16 days), and improved resource utilization.
Complete the form to access the full case study and see how Sarah Cannon redefined the delivery of complex oncology care.